BackIVERIC bio Overview

IVERIC bio Net Tangible Assets

Track IVERIC bio's net tangible assets ($480M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$477.05M
43.19% YoYΔ $143.89M vs prior year quarter

Peer average / median

Loading

IVERIC bio Net Tangible Assets History

Loading

IVERIC bio vs. peers: Net Tangible Assets Comparison

Loading

IVERIC bio Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

IVERIC bio (ISEE) FAQ

As of the most recent data (March 2023), ISEE shows a net tangible assets of $480M. That compares with $330M in the prior-year period — up 43.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ISEE's net tangible assets is now $480M (was $330M) — a 43.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether IVERIC bio is outperforming or lagging.

Tracking ISEE's net tangible assets over time shows whether IVERIC bio is scaling, shrinking, or reshaping that part of the business. The current reading is $480M That compares with $330M in the prior-year period — up 43.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has IVERIC bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $480M) with ownership activity and broader fundamentals.

IVERIC bio's net tangible assets is $480M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.